Alumni raised $1.45B in 2022 - Download Free Report Now


Small molecule drug candidates directed at ion channel targets to repurpose existing therapies for atrial fibrillation.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of ChanRx plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About ChanRx

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With